Walgreen has thrown a spanner in CVS Caremark’s attempt to acquire Longs Drug Stores by offering $3bn for Longs just before the first phase of CVS’s contested tender offer for shares of Longs was set to expire.

Walgreen’s $75 per share bid, made late on Friday, tops the CVS Caremark offer of $71.50 per share.